A Day Up For Evoke Pharma, Inc.
Mon, Jun 22, 2020 at 05:30 PM
Evoke Pharma, Inc. (EVOK:NASDAQ) rocketted at $3.8, representing a gain of 61.7%. The stock appeared on our News Catalysts scanner on Fri 19 Jun 20 at 03:46 PM in the 'BIOTECH' category. From Fri 05 Jun 20, the stock recorded 40.00% Up Days and 18.18% Green Days
The share price of the company has been moving sideways in recent weeks.
About Evoke Pharma, Inc. (EVOK:NASDAQ)
Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.
Top 10 Gainers:
- Sintx Technologies, Inc. (SINT:NASDAQ), 160.09%
- Kirkland's, Inc. (KIRK:NASDAQ), 74.38%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 61.7%
- Sierra Metals Inc. (SMTS:NYSEMKT), 55.96%
- Fuwei Films (Holdings) Co., Ltd. (FFHL:NASDAQ), 51.78%
- Ideanomics, Inc. (IDEX:NASDAQ), 48.2%
- Five Prime Therapeutics, Inc. (FPRX:NASDAQ), 45.39%
- Invitae Corporation (NVTA:NYSE), 44.58%
- Francesca's Holdings Corporation (FRAN:NASDAQ), 35.77%
- Kitov Pharma Ltd (KTOV:NASDAQ), 34.8%